Takayasu Kato

Clinical significance of disease‐specific <i><scp>MYD</scp>88</i> mutations in circulating <scp>DNA</scp> in primary central nervous system lymphoma

Keiichiro Hattori, Mamiko Sakata‐Yanagimoto, Yasuhito Suehara et al. · Cancer Science · 2017 · 78 citations · Full text

Medicine, Genetics, Oncology +17

Detection of the circulating tumor DNAs in angioimmunoblastic T- cell lymphoma

Mamiko Sakata‐Yanagimoto, Rie Nakamoto-Matsubara, Daisuke Komori et al. · Annals of Hematology · 2017 · 46 citations

Medicine, Hematology, Oncology +14

Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy

Alexander E. Perl, Richard A. Larson, Nikolai A. Podoltsev et al. · Transplantation and Cellular Therapy · 2022 · 39 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Detection of the G17V RHOA Mutation in Angioimmunoblastic T-Cell Lymphoma and Related Lymphomas Using Quantitative Allele-Specific PCR

Rie Nakamoto-Matsubara, Mamiko Sakata‐Yanagimoto, Terukazu Enami et al. · PLoS ONE · 2014 · 26 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Genetic evidence implies that primary and relapsed tumors arise from common precursor cells in primary central nervous system lymphoma

Keiichiro Hattori, Mamiko Sakata‐Yanagimoto, Manabu Kusakabe et al. · Cancer Science · 2018 · 21 citations · Full text

Medicine, Neurology, Oncology +15